Business Wire

The Qt Company Announces the Qt Automotive Suite

Share

Today, The Qt Company, creators of the Qt cross-platform development framework, together with its partners KDAB and Pelagicore announced the Qt Automotive Suite, a new product to support common In-Vehicle-Infotainment (IVI) system development needs of automotive OEMs and Tier1’s.

Today’s automakers and suppliers want to deliver an in-car experience that keeps drivers connected and informed. An experience where they can leverage a range of devices, services and where drivers can extend their work and their home into their vehicle through the connected car. Software technology is shaping the future of automotive and the user experience is what is in focus.

By combining proven components and tools used in the industry into a single offering, The Qt Automotive Suite meets the needs of automotive software solution providers with a ready-made offering. The solution is built on the Qt toolkit which encompasses libraries, tools, hardware adaptation and ready-made components. Qt is already a tried and tested mature tool within the industry powering the IVI systems of millions of cars on the road today. This new automotive development product will make it even easier and faster for OEMs and Tier1’s go to market.

Built upon the need of the automotive industry to consolidate an ever growing and complex supply chain, the Qt Automotive Suite aims to unite and simplify the tools and software components needed to create stunning, highly-performing and quickly adaptable IVI user interfaces devices.

“When building IVI systems, we see that many automotive manufacturers and providers are facing similar challenges with managing their technical solutions. The Qt Automotive Suite provides readily available components promising productivity and a high level of quality through world-class tools. This solution promises to make automotive development effortless where the UX and hardware and operating system flexibility is at the core, in turn allowing OEMs and Tier1’s concentrate on adding end-user value instead of tackling technical details.” says Petteri Holländer, Head of Product Management for the Qt Company.

The Qt Company, Pelagicore and KDAB have experience in delivering automotive UI software to over 20 automotive customers, and now they have joined their efforts in taking the Qt technology to the next level in the industry. Together, The Qt Company, KDAB and Pelagicore have created technology that elevates Qt from being a UI and application framework to being a full-fledged automotive UI software platform. Built on top of and aligned with the widely used GENIVI automotive platform architecture and leveraging the cross-platform nature of the Qt technology, there is a significant base of developers ready to take advantage of the new offering.

Qt Automotive Suite will be available under a dual-license scheme, both open source and commercial versions. The Qt Company also invites all interested parties to participate in defining related APIs under the Qt Project governance model.

“Qt Automotive Suite delivers a modern multi-process architecture enabling stunning fluid 2D and photo-realistic 3D user experiences in combination with cloud services. The dual licensing scheme enables car makers to develop an eco-system of innovation around their IVI offerings – from concept to production. We are proud to be a key contributor to Qt Automotive Suite.” says Alwin Bakkenes, CEO of Pelagicore.

“Platform-independent IVI and cluster software is a huge opportunity for the whole automotive industry. KDAB's and Pelagicore's experience with the leading industry platforms, together with the tried and true foundation that is the Qt framework, deliver an opportunity to unify the development of automotive applications, instead of doing them on a project-by-project basis,” says Kalle Dalheimer, CEO of KDAB.

More information about the Qt Automotive Suite will be presented at the Qt World Summit 2015 (Oct 6-7, Berlin) keynotes and in-depth technical strategy sessions. To register for the event, please visit www.qt.io.

For further company information please visit: About The Qt Company

To download the company logo please click here

# # #

October 2015 Ref: DQ162/A

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Contacts for Editorial Enquiries
The Qt Company
Petteri Holländer
Head of Product Management
+358 4 05 15 85 45
Petteri.Hollander@theqtcompany.com
or
Pinnacle Marketing Communications
Nevena Rasic
+44 (0) 2084 296 541
n.rasic@pinnaclemarcom.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

H.I.G. Capital Acquires Morningside Healthcare and Morningside Pharmaceuticals3.10.2022 14:00:00 CEST | Press release

H.I.G. Capital, LLC (“H.I.G.”), a leading global alternative investment firm with over $50 billion of equity capital under management, is pleased to announce that its portfolio company Aspire Pharma has acquired Morningside Healthcare and Morningside Pharmaceuticals (together “Morningside” or the “Company”), a leading UK provider of niche generic and branded specialty pharmaceuticals. The financial terms of the transaction have not been disclosed. Morningside, established in 1991 in the UK, is focused on developing and licensing niche generic pharmaceutical products. The business markets over 160 SKUs across more than 80 product families and multiple therapeutical areas, including Endocrine, Psychiatry, CNS, Infectious and Gastro. H.I.G. is combining Morningside with Aspire Pharma to build on their combined track record of organic growth, product development, and support new initiatives, such as M&A and international expansion. Richard Condon (CEO, Aspire) remarked, “We are excited to

Sonitor ® Technologies Prepares for Accelerated Growth3.10.2022 13:58:00 CEST | Press release

Sonitor Technologies AS, the global leader in ultrasound-based, indoor positioning technology, today announced that it will merge its Forkbeard and Sonitor Technologies subsidiaries as it prepares for accelerated revenue growth with the market entry of Forkbeard, the company’s cloud-based, product platform for indoor positioning of smart mobile devices “We are at the beginning of an exciting new chapter in our company history,” said Arne Oyen, Group President and CEO of Sonitor Technologies AS. “This merger of our subsidiaries strengthens our focus and resources as we expand our global market presence. Forkbeard can deliver the many benefits of indoor positioning and proximity monitoring to every user of a smart phone or tablet. We will build on the strong commercial franchise that Sonitor has established in acute care and senior living with its market leading Sonitor Sense™ platform and expand into other industry sectors, such as manufacturing. Going forward, the merged company will b

Alpago Properties Sells the Most Expensive Signature Villa in the Dubai Property Market for AED 302.5M (82M $)3.10.2022 13:03:00 CEST | Press release

Alpago Properties entered the record books in the Dubai real estate market with the sale of their groundbreaking double signature villa, Casa Del Sole, on Palm Jumeirah’s Billionaires’ Row for AED 302.5M. Known as a leading high-end real estate developer shaping the landscape of Dubai, and in particular Frond G on the Palm Jumeirah, Alpago Properties has now just recorded the biggest villa sale in the UAE’s real estate sold through their exclusive broker B1 Properties and was designed by SOATA and CK Architecture. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221003005475/en/ Senior officials from Alpago Properties, Nakheel, B1 Properties and CK Architecture (Photo: AETOSWire) The villa sale was announced at an exclusive private event in the presence of officials from Alpago Properties and Nakheel along with media representatives. The double signature villa sale is set to change Dubai’s luxury property market. This momentou

Rockwell Automation Announces Intent to Acquire CUBIC3.10.2022 13:00:00 CEST | Press release

Rockwell Automation, Inc. (NYSE: ROK), the world’s largest company dedicated to industrial automation and digital transformation, today announced that it has signed a definitive agreement to acquire CUBIC, a company that specializes in modular systems for the construction of electrical panels. CUBIC, founded in 1973, serves fast-growing industries, such as renewable energy, data centers, and infrastructure, and is headquartered in Bronderslev, Denmark. CUBIC’s efficient and flexible modular systems combined with Rockwell’s intelligent devices and industry expertise will benefit customers by offering faster time to market, enabling broader plant-wide applications for intelligent motor control, and generating smart data to increase sustainability and productivity. CUBIC’s established partner model will allow Rockwell to build an expanded Partner Network for intelligent motor control offerings in Asia, Europe, and Latin America. The company will bring new customers and partners in hybrid

Incyte Announces Agreement to Acquire Medicxi-backed Villaris Therapeutics and Auremolimab (VM6), an Anti-IL-15Rβ Monoclonal Antibody3.10.2022 12:00:00 CEST | Press release

Incyte (NASDAQ:INCY) today announced that the Company has entered into an agreement to acquire Villaris Therapeutics, an asset-centric biopharmaceutical company seeded by Medicxi and focused on the development of novel antibody therapeutics for vitiligo. Its lead asset, auremolimab (VM6), an anti-IL-15Rβ monoclonal antibody (mAb), is expected to enter clinical development in 2023. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221003005269/en/ Under the terms of the agreement, Incyte will acquire Villaris and the exclusive global rights to develop and commercialize auremolimab for all uses, including in vitiligo and other autoimmune and inflammatory diseases. Incyte will make an upfront payment of $70 million, and Villaris shareholders will be eligible for up to $310 million upon achievement of certain development and regulatory milestones, as well as up to an additional $1.05 billion in commercial milestones on net sales of